BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38212709)

  • 1. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting as recurrent aseptic peritonitis in a patient receiving peritoneal dialysis: a case report.
    Fukuda N; Kanai D; Hoshino K; Fukuda Y; Morita R; Ishikawa Y; Kanaoka T; Toya Y; Kirino Y; Wakui H; Tamura K
    BMC Nephrol; 2024 Jan; 25(1):18. PubMed ID: 38212709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome.
    Matsumoto H; Fujita Y; Fukatsu M; Ikezoe T; Yokose K; Asano T; Tsuchida N; Maeda A; Yoshida S; Hashimoto H; Temmoku J; Matsuoka N; Yashiro-Furuya M; Sato S; Murakami M; Sato H; Sakuma C; Kawashima K; Shakespear N; Uchiyama Y; Watanabe H; Kirino Y; Matsumoto N; Migita K
    Front Immunol; 2022; 13():897722. PubMed ID: 35757758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment.
    Tozaki N; Tawada C; Niwa H; Mizutani Y; Shu E; Kawase A; Miwa Y; Ohnishi H; Sasai H; Miyako K; Hosokawa J; Kato A; Kobayashi K; Miyazaki T; Shirakami Y; Shimizu M; Iwata H
    Front Med (Lausanne); 2022; 9():1046820. PubMed ID: 36544501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
    Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
    Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
    Comont T; Heiblig M; Rivière E; Terriou L; Rossignol J; Bouscary D; Rieu V; Le Guenno G; Mathian A; Aouba A; Vinit J; Dion J; Kosmider O; Terrier B; Georgin-Lavialle S; Fenaux P; Mekinian A;
    Br J Haematol; 2022 Feb; 196(4):969-974. PubMed ID: 34651299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute heart failure due to left common iliac arteriovenous fistula: A case of VEXAS syndrome.
    Yamaguchi H; Kobayashi D; Nakamura G; Aida R; Horii Y; Okamoto T; Murakami S; Kondo D; Tsuchida N; Uchiyama Y; Maeda A; Kirino Y; Matsumoto N; Kurosawa Y; Hasegawa E; Wakamatsu A; Narita I
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):327-333. PubMed ID: 36264203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A "Leopard Man" Aspect on 18 F-FDG PET/CT Revealing a VEXAS Syndrome.
    Fagart A; Quemeneur T; Collet G; Demailly F; Rousselin C
    Clin Nucl Med; 2023 Jan; 48(1):e33-e34. PubMed ID: 36252945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortitis PET Imaging in VEXAS Syndrome: A Case Report.
    Grambow-Velilla J; Braun T; Pop G; Louzoun A; Soussan M
    Clin Nucl Med; 2023 Feb; 48(2):e67-e68. PubMed ID: 36607374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases.
    Vitale A; Caggiano V; Bimonte A; Caroni F; Tosi GM; Fabbiani A; Renieri A; Bocchia M; Frediani B; Fabiani C; Cantarini L
    Intern Emerg Med; 2023 Apr; 18(3):711-722. PubMed ID: 36662445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
    van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
    J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome in the intensive care unit: a case report.
    Belicard F; Belhomme N; Bouzy S; Saillard C; Nedelec F; Mear JB; Ardois S; Pastoret C; Reizine F; Camus C; Painvin B
    J Med Case Rep; 2023 Jul; 17(1):314. PubMed ID: 37480098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEXAS syndrome: Clinical manifestations, diagnosis, and treatment.
    Loeza-Uribe MP; Hinojosa-Azaola A; Sánchez-Hernández BE; Crispín JC; Apodaca-Chávez E; Ferrada MA; Martín-Nares E
    Reumatol Clin (Engl Ed); 2024 Jan; 20(1):47-56. PubMed ID: 38160120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of VEXAS: Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic Syndrome With Co-existing DNA (Cytosine-5)-Methyltransferase 3A Mutation Complicated by Localized Skin Reaction to Tocilizumab and Azacitidine.
    Estes J; Malus M; Wilson L; Grayson PC; Maz M
    Cureus; 2023 Jun; 15(6):e39906. PubMed ID: 37404435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A man in his sixties with chondritis and bone marrow failure.
    Midtvedt Ø; Stray-Pedersen A; Andersson H; Gunnarsson R; Tveten K; Ali MM; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2022 Mar; 142(4):. PubMed ID: 35239266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEXAS Syndrome: A Novelty in MDS Landscape.
    Templé M; Kosmider O
    Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic Mutations in
    Beck DB; Ferrada MA; Sikora KA; Ombrello AK; Collins JC; Pei W; Balanda N; Ross DL; Ospina Cardona D; Wu Z; Patel B; Manthiram K; Groarke EM; Gutierrez-Rodrigues F; Hoffmann P; Rosenzweig S; Nakabo S; Dillon LW; Hourigan CS; Tsai WL; Gupta S; Carmona-Rivera C; Asmar AJ; Xu L; Oda H; Goodspeed W; Barron KS; Nehrebecky M; Jones A; Laird RS; Deuitch N; Rowczenio D; Rominger E; Wells KV; Lee CR; Wang W; Trick M; Mullikin J; Wigerblad G; Brooks S; Dell'Orso S; Deng Z; Chae JJ; Dulau-Florea A; Malicdan MCV; Novacic D; Colbert RA; Kaplan MJ; Gadina M; Savic S; Lachmann HJ; Abu-Asab M; Solomon BD; Retterer K; Gahl WA; Burgess SM; Aksentijevich I; Young NS; Calvo KR; Werner A; Kastner DL; Grayson PC
    N Engl J Med; 2020 Dec; 383(27):2628-2638. PubMed ID: 33108101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
    Kunimoto H; Miura A; Maeda A; Tsuchida N; Uchiyama Y; Kunishita Y; Nakajima Y; Takase-Minegishi K; Yoshimi R; Miyazaki T; Hagihara M; Yamazaki E; Kirino Y; Matsumoto N; Nakajima H
    Int J Hematol; 2023 Oct; 118(4):494-502. PubMed ID: 37062784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vacuoles in bone marrow progenitors: VEXAS syndrome and beyond.
    Lacombe V; Hadjadj J; Georgin-Lavialle S; Lavigne C; Geneviève F; Kosmider O
    Lancet Haematol; 2024 Feb; 11(2):e160-e167. PubMed ID: 38302223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome.
    Kataoka A; Mizumoto C; Kanda J; Iwasaki M; Sakurada M; Oka T; Fujimoto M; Yamamoto Y; Yamashita K; Nannya Y; Ogawa S; Takaori-Kondo A
    Int J Hematol; 2023 Jun; 117(6):919-924. PubMed ID: 36641501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia.
    Austestad J; Madland TM; Sandnes M; Haslerud TM; Benneche A; Reikvam H
    Case Rep Hematol; 2023; 2023():6551544. PubMed ID: 36879894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.